No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Javed Butler, MD
PeerThe Network Effect: Analyzing Brain Structures to Treat Depression
Conor Liston, MD, PhD
PeerEarly aggressive lipid-lowering strategy with PCSK9 siRNA performs better than usual care in US patients with ASCVD
Michael Koren, MD
PeerMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Daniel Gaudet, MD, PhD
PeerStopping aspirin after 1 month DAPT in ACS patients after stenting
Gregg Stone, MD
PeerThe Gene Messenger: Advancing Neurological Gene Therapy
Michael Kaplitt, MD, PhD
PeerDeep Learner: Building AI to Improve Cardiovascular Care
Pierre Elias, MD
PeerMike Sharma, MD, MSc, FRCPC
PeerSevere Asthma: An Exploratory Study on Mucus Plugging
Managing AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
Steven Nissen, MD
PeerUnveiling the Numerous Benefits of RTA Prefilled Syringes
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Michael Bloch, MD
PeerAdvancing the Science of Anemia Due to CKD
APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk
Brian Bergmark, MD
Peer